Death risk higher with conventional than with atypical antipsychotics Clinical study 09 February 2013 Pages: 2 - 2
Fatal sepsis with mifepristone, but no need to abort the drug News item 09 February 2013 Pages: 3 - 3
Creativity inappropriate in approval process for antineoplastics News item 09 February 2013 Pages: 4 - 4
Moxifloxacin, nonstandardised antibacterials equivalent in CAP Clinical study 09 February 2013 Pages: 4 - 4
Aggressive treatment of heart failure decreases costs and hospitalisation Clinical study 09 February 2013 Pages: 7 - 7
Metal on metal hip resurfacing “extremely cost-effective” Clinical study 09 February 2013 Pages: 7 - 7
Benzylguanine + temozolomide in children with solid tumours Clinical study 09 February 2013 Pages: 8 - 8
C. difficile evades fluoroquinolones, cephalosporins and rampages News item 09 February 2013 Pages: 11 - 11
Artemisinin resistance may be due to S769N PfATPase mutation News item 09 February 2013 Pages: 12 - 12
Bicalutamide beneficial in locally-advanced prostate cancer Clinical study 09 February 2013 Pages: 12 - 12
Higher dose chemo means higher survival rates in breast cancer Clinical study 09 February 2013 Pages: 12 - 12
Antiretrovirals effective in Haiti: hope for the developing world News item 09 February 2013 Pages: 14 - 14
Perindopril/indapamide superior to enalapril in hypertension Clinical study 09 February 2013 Pages: 14 - 14
Clotrimazole more than doubles tacrolimus bioavailability Clinical study 09 February 2013 Pages: 15 - 15
US NovoSeven labelling update includes new AEs and warnings News item 09 February 2013 Pages: 16 - 16
High renal impairment rate with zoledronic acid in cancer patients News item 09 February 2013 Pages: 17 - 17
Ranbaxy Laboratories introduces HAART products in India Media release 09 February 2013 Pages: 17 - 17
US NeutroSpec labelling under review after serious ADR reports News item 09 February 2013 Pages: 17 - 17